184 related articles for article (PubMed ID: 10574597)
21. The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin.
Watanabe T; Hotta T; Ichikawa A; Kinoshita T; Nagai H; Uchida T; Murate T; Saito H
Blood; 1994 Nov; 84(9):3158-65. PubMed ID: 7949188
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
23. Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma.
Møller MB; Gerdes AM; Skjødt K; Mortensen LS; Pedersen NT
Clin Cancer Res; 1999 May; 5(5):1085-91. PubMed ID: 10353742
[TBL] [Abstract][Full Text] [Related]
24. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
Shi YF; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
[TBL] [Abstract][Full Text] [Related]
26. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
Cogliatti SB; Griesser H; Peng H; Du MQ; Isaacson PG; Zimmermann DR; Maibach RC; Schmid U
J Pathol; 2000 Dec; 192(4):470-8. PubMed ID: 11113864
[TBL] [Abstract][Full Text] [Related]
27. MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S; Takami K; Nakayama T; Nishisho I
Br J Cancer; 1997; 75(9):1302-8. PubMed ID: 9155050
[TBL] [Abstract][Full Text] [Related]
28. p53 and MDM2 in the development and progression of bladder cancer.
Schmitz-Dräger BJ; Kushima M; Goebell P; Jax TW; Gerharz CD; Bültel H; Schulz WA; Ebert T; Ackermann R
Eur Urol; 1997; 32(4):487-93. PubMed ID: 9412812
[TBL] [Abstract][Full Text] [Related]
29. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
[TBL] [Abstract][Full Text] [Related]
30. mdm2 expression as a prognostic indicator in clear cell renal cell carcinoma: comparison with p53 overexpression and clinicopathological parameters.
Haitel A; Wiener HG; Baethge U; Marberger M; Susani M
Clin Cancer Res; 2000 May; 6(5):1840-4. PubMed ID: 10815906
[TBL] [Abstract][Full Text] [Related]
31. bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach.
Omonishi K; Yoshino T; Sakuma I; Kobayashi K; Moriyama M; Akagi T
Mod Pathol; 1998 Feb; 11(2):181-5. PubMed ID: 9504689
[TBL] [Abstract][Full Text] [Related]
32. Altered patterns of MDM2 and TP53 expression in human bladder cancer.
Lianes P; Orlow I; Zhang ZF; Oliva MR; Sarkis AS; Reuter VE; Cordon-Cardo C
J Natl Cancer Inst; 1994 Sep; 86(17):1325-30. PubMed ID: 8064890
[TBL] [Abstract][Full Text] [Related]
33. mdm-2 oncogene expression in non-Hodgkin's lymphomas.
Kawamata N; Miller C; Levy V; Shintaku IP; Koeffler HP; Said JW
Diagn Mol Pathol; 1996 Mar; 5(1):33-8. PubMed ID: 8919543
[TBL] [Abstract][Full Text] [Related]
34. Elevated levels of MDM-2 and p53 expression are associated with high grade non-Hodgkin's lymphomas.
Finnegan MC; Goepel JR; Royds J; Hancock BW; Goyns MH
Cancer Lett; 1994 Nov; 86(2):215-21. PubMed ID: 7982210
[TBL] [Abstract][Full Text] [Related]
35. Over-expression of the MDM2 gene is found in some cases of haematological malignancies.
Quesnel B; Preudhomme C; Oscier D; Lepelley P; Collyn-d'Hooghe M; Facon T; Zandecki M; Fenaux P
Br J Haematol; 1994 Oct; 88(2):415-8. PubMed ID: 7803295
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis-associated proteins in oral lymphomas from HIV-positive patients.
Regezi JA; McMillan A; Dekker N; Daniels TE; Silverman S; Schoelch M; Ziober BL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Aug; 86(2):196-202. PubMed ID: 9720096
[TBL] [Abstract][Full Text] [Related]
37. Detection of the apoptosis-suppressing oncoprotein bcl-2 in salivary gland lymphoma.
Takahashi H; Fujita S; Shibata Y; Okabe H; Hideshima K; Tsuda N
Pathol Res Pract; 1998; 194(3):163-70. PubMed ID: 9587934
[TBL] [Abstract][Full Text] [Related]
38. Increased MDM2 expression is associated with inferior survival in mantle-cell lymphoma, but not related to the MDM2 SNP309.
Hartmann E; Fernàndez V; Stoecklein H; Hernández L; Campo E; Rosenwald A
Haematologica; 2007 Apr; 92(4):574-5. PubMed ID: 17488676
[TBL] [Abstract][Full Text] [Related]
39. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
[TBL] [Abstract][Full Text] [Related]
40. Strong correlation of basement membrane degradation with p53 inactivation and/or MDM2 overexpression in superficial urothelial carcinomas.
Ozdemir E; Kakehi Y; Okuno H; Habuchi T; Okada Y; Yoshida O
J Urol; 1997 Jul; 158(1):206-11. PubMed ID: 9186361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
